{"database": "lobbying", "table": "lobbying_activities", "rows": [[2862008, "4004dec9-cbeb-4f6a-8089-72398e5e8304", "3T", "WELSH ROSE, LLC", 401104285, "ALNYLAM PHARMACEUTICALS, INC.", 2022, "third_quarter", "MMM", "REFUND Act; home infusion issues and April 2021 Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS).", "HOUSE OF REPRESENTATIVES", null, null, 0, 1, "2022-10-10T16:22:52-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2862008"], "units": {}, "query_ms": 142.3512559849769, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}